Anti-ron antibodies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8829164
SERIAL NO

14070070

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Monoclonal antibodies that bind and inhibit activation of human RON (Recepteur d'Origine Nantais) are disclosed. The antibodies can be used to treat certain forms of cancer that are associated with activation of RON.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AVEO PHARMACEUTICALS INC30 WINTER STREET BOSTON MA 02108

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bottega, Steve Cambridge, US 10 43
Boudrow, Andrea Peabody, US 2 15
Breault, Lyne Roslindale, US 19 231
Chen, Ting Acton, US 211 4505
Gifford, James Somerville, US 15 34
Gyuris, Jeno Lincoln, US 63 604
Han, May Brookline, US 15 121
Jiang, Jinwei Chestnut Hill, US 5 53
Lerner, Lorena Newton Centre, US 30 101
Liu, Qing Acton, US 537 5415
Meetze, Kristan Lexington, US 22 178
Vincent, Sylvie Somerville, US 10 85
Weiler, Solly Newton, US 17 213
Whalen, Kerry Chelmsford, US 16 46
Winston,, Jr William M Marlborough, US 32 270

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 9, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00